Tapewire

Nasdaq · USD

EDIT

Editas Medicine, Inc.

Export transactions ↓
Tapewire entity
5502
SEC CIK
0001650664
Parsed reports
306

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202600
Feb 202600
Mar 202603
Apr 202600
May 202600
Jun 202603
Jul 202601
Aug 202601
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 08, 2026 Filed Sep 9, 2026 20:58 UTC
Ory Daniel ScottEVP, Chief Medical Officer
GrantStock Option (right to buy) · Derivative 950,000 $0.00 Strike: $3.03 $0.00
Disclosure

SEC source: 0002149618-26-000006 · wk-form4_1788987497.xml · derivative · entry 1

Ory Daniel Scott · CIK 0002149618 · EVP, Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 950,000

Underlying: Common Stock · 950,000 shares

Expires 2036-09-07

F1 · derivative.exercise_date: This option was granted on September 8, 2026 and is scheduled to vest over four years, with 25% of the shares to vest on October 15, 2027 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 15, 2030.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:27 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 709 $3.04 $2,153.37
Disclosure

SEC source: 0001985604-26-000003 · wk-form4_1788553659.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,660

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $3.0050 to $3.0372. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:25 UTC
Parison AmySVP, Chief Financial Officer
SaleCommon Stock 453 $3.04 $1,375.85
Disclosure

SEC source: 0002063082-26-000006 · wk-form4_1788553522.xml · nonDerivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,839

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:22 UTC
O'Neill Gilmore NeilDirector · CEO
SaleCommon Stock 5,124 $3.04 $15,562.61
Disclosure

SEC source: 0001742084-26-000003 · wk-form4_1788553359.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 243,189

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $3.0050 to $3.0372. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 06, 2026 Filed Aug 7, 2026 21:16 UTC GrantStock Option (right to buy) · Derivative 103,400 $0.00 Strike: $2.90 $0.00
Disclosure

SEC source: 0002137699-26-000004 · wk-form4_1786137389.xml · derivative · entry 1

Ellinor Patrick Thomas II · CIK 0002137699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,400

Underlying: Common Stock · 103,400 shares

Expires 2036-08-05

F1 · derivative.exercise_date: This option was granted on August 6, 2026 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on August 6, 2027 through August 6, 2029.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:07 UTC
Parison AmySVP, Chief Financial Officer
SaleCommon Stock 678 $2.58 $1,749.24
Disclosure

SEC source: 0002063082-26-000003 · wk-form4_1785960474.xml · nonDerivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,292

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 1, 2026. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
July 28, 2026 Filed Jul 29, 2026 20:51 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 4,928 $2.67 $13,157.76
Disclosure

SEC source: 0001650664-26-000076 · wk-form4_1785358259.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,369

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2026. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:28 UTC GrantStock Option (right to buy) · Derivative 51,700 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001650664-26-000068 · wk-form4_1782160133.xml · derivative · entry 1

Levy Elliott M. · CIK 0001858745 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,700

Underlying: Common Stock · 51,700 shares

Expires 2036-06-16

F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:30 UTC GrantStock Option (right to buy) · Derivative 51,700 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001650664-26-000070 · wk-form4_1782160207.xml · derivative · entry 1

Hirsch Andrew · CIK 0001586707 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,700

Underlying: Common Stock · 51,700 shares

Expires 2036-06-16

F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:30 UTC GrantStock Option (right to buy) · Derivative 51,700 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001650664-26-000071 · wk-form4_1782160247.xml · derivative · entry 1

Hopfield Jessica · CIK 0001648715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,700

Underlying: Common Stock · 51,700 shares

Expires 2036-06-16

F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:29 UTC GrantStock Option (right to buy) · Derivative 51,700 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001650664-26-000069 · wk-form4_1782160170.xml · derivative · entry 1

Scadden David · CIK 0001707715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,700

Underlying: Common Stock · 51,700 shares

Expires 2036-06-16

F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027.

Read SEC document
June 17, 2026 Filed Jun 22, 2026 20:31 UTC GrantStock Option (right to buy) · Derivative 51,700 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0001650664-26-000072 · wk-form4_1782160274.xml · derivative · entry 1

Connaughton Bernadette · CIK 0001662521 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,700

Underlying: Common Stock · 51,700 shares

Expires 2036-06-16

F1 · derivative.exercise_date: This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 20:33 UTC
Parison AmySVP, Chief Financial Officer
SaleCommon Stock 464 $2.70 $1,253.26
Disclosure

SEC source: 0001650664-26-000057 · wk-form4_1780691609.xml · nonDerivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,970

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7049. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 20:32 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 731 $2.70 $1,974.50
Disclosure

SEC source: 0001650664-26-000055 · wk-form4_1780691552.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,297

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7050. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 20:33 UTC
O'Neill Gilmore NeilDirector · CEO
SaleCommon Stock 15,380 $2.70 $41,542.92
Disclosure

SEC source: 0001650664-26-000056 · wk-form4_1780691579.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 248,313

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7250. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 20:34 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
GrantStock Option (right to buy) · Derivative 292,856 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001650664-26-000021 · wk-form4_1773693286.xml · derivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 292,856

Underlying: Common Stock · 292,856 shares

Expires 2036-03-11

F1 · derivative.exercise_date: This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 20:37 UTC
O'Neill Gilmore NeilDirector · CEO
GrantStock Option (right to buy) · Derivative 1,015,200 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001650664-26-000023 · wk-form4_1773693426.xml · derivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,015,200

Underlying: Common Stock · 1,015,200 shares

Expires 2036-03-11

F1 · derivative.exercise_date: This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 20:35 UTC
Parison AmySVP, Chief Financial Officer
GrantStock Option (right to buy) · Derivative 292,856 $0.00 Strike: $2.54 $0.00
Disclosure

SEC source: 0001650664-26-000022 · wk-form4_1773693348.xml · derivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 292,856

Underlying: Common Stock · 292,856 shares

Expires 2036-03-11

F1 · derivative.exercise_date: This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030.

Read SEC document
March 03, 2026 Filed Mar 4, 2026 21:56 UTC
O'Neill Gilmore NeilDirector · CEO
SaleCommon Stock 5,394 $2.02 $10,894.26
Disclosure

SEC source: 0001650664-26-000009 · wk-form4_1772661358.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 263,693

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204 The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2026 Filed Mar 4, 2026 21:49 UTC
Parison AmySVP, Chief Financial Officer
SaleCommon Stock 474 $2.02 $957.48
Disclosure

SEC source: 0001650664-26-000007 · wk-form4_1772660958.xml · nonDerivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,434

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0050 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 03, 2026 Filed Mar 4, 2026 21:48 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 749 $2.02 $1,512.68
Disclosure

SEC source: 0001650664-26-000006 · wk-form4_1772660918.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,028

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0041 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected

Read SEC document
December 03, 2025 Filed Dec 4, 2025 21:39 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 713 $2.15 $1,535.16
Disclosure

SEC source: 0001650664-25-000163 · wk-form4_1764884348.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,777

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 21:38 UTC
O'Neill Gilmore NeilDirector · CEO
SaleCommon Stock 5,603 $2.15 $12,063.82
Disclosure

SEC source: 0001650664-25-000162 · wk-form4_1764884318.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 269,087

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
December 03, 2025 Filed Dec 4, 2025 21:38 UTC
Parison AmySVP, Chief Financial Officer
SaleCommon Stock 461 $2.15 $992.58
Disclosure

SEC source: 0001650664-25-000161 · wk-form4_1764884284.xml · nonDerivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,908

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 20:20 UTC
Parison AmySVP, Chief Financial Officer
SaleCommon Stock 458 $2.60 $1,189.01
Disclosure

SEC source: 0001650664-25-000142 · wk-form4_1757017244.xml · nonDerivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,369

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 20:21 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 710 $2.60 $1,843.23
Disclosure

SEC source: 0001650664-25-000143 · wk-form4_1757017284.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,490

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: The amount of securities beneficially owned following the reported transaction includes 5,802 shares acquired under the Issuer's Employee Stock Purchase Plan.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 20:20 UTC
O'Neill Gilmore NeilDirector · CEO
SaleCommon Stock 5,592 $2.60 $14,517.39
Disclosure

SEC source: 0001650664-25-000141 · wk-form4_1757017197.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 274,690

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
August 07, 2025 Filed Aug 8, 2025 20:28 UTC
Parison AmySVP, Chief Financial Officer
SaleCommon Stock 679 $2.58 $1,751.82
Disclosure

SEC source: 0001650664-25-000118 · wk-form4_1754684878.xml · nonDerivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,827

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 6, 2025. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
July 31, 2025 Filed Aug 4, 2025 20:49 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 5,121 $2.49 $12,756.92
Disclosure

SEC source: 0001650664-25-000113 · wk-form4_1754340586.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,398

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2025. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:18 UTC GrantStock Option (right to buy) · Derivative 37,500 $0.00 Strike: $1.91 $0.00
Disclosure

SEC source: 0001650664-25-000101 · wk-form4_1749586723.xml · derivative · entry 1

Levy Elliott M. · CIK 0001858745 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:18 UTC GrantStock Option (right to buy) · Derivative 37,500 $0.00 Strike: $1.91 $0.00
Disclosure

SEC source: 0001650664-25-000099 · wk-form4_1749586673.xml · derivative · entry 1

Hirsch Andrew · CIK 0001586707 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:19 UTC GrantStock Option (right to buy) · Derivative 37,500 $0.00 Strike: $1.91 $0.00
Disclosure

SEC source: 0001650664-25-000103 · wk-form4_1749586773.xml · derivative · entry 1

Hopfield Jessica · CIK 0001648715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:19 UTC GrantStock Option (right to buy) · Derivative 37,500 $0.00 Strike: $1.91 $0.00
Disclosure

SEC source: 0001650664-25-000102 · wk-form4_1749586749.xml · derivative · entry 1

Scadden David · CIK 0001707715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026.

Read SEC document
June 06, 2025 Filed Jun 10, 2025 20:18 UTC GrantStock Option (right to buy) · Derivative 37,500 $0.00 Strike: $1.91 $0.00
Disclosure

SEC source: 0001650664-25-000100 · wk-form4_1749586697.xml · derivative · entry 1

Connaughton Bernadette · CIK 0001662521 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2035-06-05

F1 · derivative.exercise_date: This option was granted on June 6, 2025 and is scheduled to vest in full on June 6, 2026.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 22:39 UTC
Parison AmySVP, Chief Financial Officer
SaleCommon Stock 446 $1.72 $768.90
Disclosure

SEC source: 0001650664-25-000093 · wk-form4_1749076755.xml · nonDerivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,506

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 22:37 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 726 $1.72 $1,251.84
Disclosure

SEC source: 0001650664-25-000091 · wk-form4_1749076666.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,519

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 03, 2025 Filed Jun 4, 2025 22:36 UTC
O'Neill Gilmore NeilDirector · CEO
SaleCommon Stock 15,192 $1.72 $26,195.57
Disclosure

SEC source: 0001650664-25-000089 · wk-form4_1749076593.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 280,282

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7566 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 08, 2025 Filed Apr 8, 2025 20:29 UTC
Parison AmySVP, Chief Financial Officer
GrantStock Option (right to buy) · Derivative 34,672 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001650664-25-000052 · wk-form4_1744144175.xml · derivative · entry 1

Parison Amy · CIK 0002063082 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,672

Underlying: Common Stock · 34,672 shares

Expires 2035-04-07

F1 · derivative.exercise_date: This option was granted on April 8, 2025 and is scheduled to vest over four years, with 25% of the shares to vest on April 8, 2026 and the remaining 75% of the shares scheduled to vest in equal monthly monthly installments thereafter through April 8, 2029.

Read SEC document
March 08, 2025 Filed Mar 27, 2025 20:41 UTC
Lucera ErickEVP, CHIEF FINANCIAL OFFICER
GrantStock Option (right to buy) · Derivative 70,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001650664-25-000040 · wk-form4_1743108110.xml · derivative · entry 2

Lucera Erick · CIK 0001697616 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2035-03-07

F2 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026.

Read SEC document
March 08, 2025 Filed Mar 27, 2025 20:41 UTC
Lucera ErickEVP, CHIEF FINANCIAL OFFICER
GrantStock Option (right to buy) · Derivative 275,100 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001650664-25-000040 · wk-form4_1743108110.xml · derivative · entry 1

Lucera Erick · CIK 0001697616 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,100

Underlying: Common Stock · 275,100 shares

Expires 2035-03-07

F1 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029.

Read SEC document
March 08, 2025 Filed Mar 27, 2025 20:37 UTC
O'Neill Gilmore NeilDirector · CEO
GrantStock Option (right to buy) · Derivative 175,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001650664-25-000037 · wk-form4_1743107853.xml · derivative · entry 2

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2035-03-07

F2 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026.

Read SEC document
March 08, 2025 Filed Mar 27, 2025 20:37 UTC
O'Neill Gilmore NeilDirector · CEO
GrantStock Option (right to buy) · Derivative 828,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001650664-25-000037 · wk-form4_1743107853.xml · derivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 828,000

Underlying: Common Stock · 828,000 shares

Expires 2035-03-07

F1 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029.

Read SEC document
March 08, 2025 Filed Mar 27, 2025 20:33 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
GrantStock Option (right to buy) · Derivative 70,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001650664-25-000034 · wk-form4_1743107610.xml · derivative · entry 2

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2035-03-07

F2 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026.

Read SEC document
March 08, 2025 Filed Mar 27, 2025 20:33 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
GrantStock Option (right to buy) · Derivative 275,100 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001650664-25-000034 · wk-form4_1743107610.xml · derivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,100

Underlying: Common Stock · 275,100 shares

Expires 2035-03-07

F1 · derivative.exercise_date: This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:44 UTC
Lucera ErickEVP, CHIEF FINANCIAL OFFICER
SaleCommon Stock 4,109 $1.71 $7,029.68
Disclosure

SEC source: 0001650664-25-000027 · wk-form4_1741211041.xml · nonDerivative · entry 1

Lucera Erick · CIK 0001697616 · EVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,720

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on May 12, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 3, 2025. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7107 to $1.7150 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:43 UTC
O'Neill Gilmore NeilDirector · CEO
SaleCommon Stock 16,632 $1.71 $28,452.36
Disclosure

SEC source: 0001650664-25-000026 · wk-form4_1741210979.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 295,474

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 3, 2025. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.7107 to $1.7125 . The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:41 UTC
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER
SaleCommon Stock 2,891 $1.71 $4,945.63
Disclosure

SEC source: 0001650664-25-000025 · wk-form4_1741210903.xml · nonDerivative · entry 1

Burkly Linda · CIK 0001985604 · EVP, CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,245

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
December 03, 2024 Filed Dec 5, 2024 21:40 UTC
O'Neill Gilmore NeilDirector · CEO
SaleCommon Stock 1,618 $2.08 $3,361.23
Disclosure

SEC source: 0001650664-24-000126 · wk-form4_1733434825.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 312,106

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0550 to $2.0783. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 03, 2024 Filed Dec 5, 2024 21:37 UTC
Mei BaisongEVP, CHIEF MEDICAL OFFICER
SaleCommon Stock 541 $2.08 $1,123.77
Disclosure

SEC source: 0001650664-24-000124 · wk-form4_1733434638.xml · nonDerivative · entry 1

Mei Baisong · CIK 0001938499 · EVP, CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,354

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $2.0507 to $2.0783. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 04, 2024 Filed Sep 6, 2024 20:20 UTC
Mei BaisongEVP, CHIEF MEDICAL OFFICER
SaleCommon Stock 518 $3.42 $1,773.99
Disclosure

SEC source: 0001650664-24-000105 · wk-form4_1725654028.xml · nonDerivative · entry 1

Mei Baisong · CIK 0001938499 · EVP, CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,895

F1 · kind: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $3.4246 to $3.4501. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.